aTyr Pharma Inc LIFE:NASDAQ

Last Price$7.80NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/03/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$7.80 (2)
Ask (Size)$8.20 (3)
Day Low / HighN/A - N/A
Volume271.8 K
 

View Biotechnology IndustryPeer Comparison as of 12/03/2021

 

aTyr Pharma Inc ( NASDAQ )

Price: $7.80
Change: -0.26 (3.23%)
Volume: 271.8 K
4:00PM ET 12/03/2021
 
 

Syros Pharmaceuticals Inc ( NASDAQ )

Price: $3.55
Change: -0.27 (7.07%)
Volume: 343.0 K
4:00PM ET 12/03/2021
 
 

Cardiff Oncology Inc ( NASDAQ )

Price: $5.24
Change: -0.22 (4.03%)
Volume: 441.5 K
4:00PM ET 12/03/2021
 
 

Leap Therapeutics Inc ( NASDAQ )

Price: $2.39
Change: -0.13 (5.16%)
Volume: 1.7 M
4:00PM ET 12/03/2021
 
 

Spectrum Pharmaceuticals Inc ( NASDAQ )

Price: $1.37
Change: -0.21 (13.29%)
Volume: 3.6 M
4:00PM ET 12/03/2021
 

Read more news Recent News

ATyr Pharma, Fujifilm Diosynth Biotechnologies Enter Manufacturing Agreement for ATYR1923
3:00PM ET 11/30/2021 MT Newswires

ATyr Pharma (LIFE) said Tuesday it entered a manufacturing agreement with Fujifilm Diosynth Biotechnologies for the production of a prospective pulmonary...

--HC Wainwright Adjusts aTyr Pharma's Price Target to $11 from $18, Keeps Buy Rating
12:39PM ET 11/11/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--RBC Initiates aTyr Pharma at Outperform, Speculative Risk, Sets Price Target at $22, Says Lead Product is Underappreciated
8:08AM ET 10/12/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Piper Sandler Starts aTyr Pharma at Overweight With $19 Price Target
7:22AM ET 9/21/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Company Profile

Business DescriptionaTyr Pharma, Inc. engages in the discovery and development of medicines based on novel immunological pathways. Its product pipeline include ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1;DARS-1(3). The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA. View company web site for more details
Address3545 John Hopkins Court
San Diego, California 92121
Phone+1.858.731.8389
Number of Employees42
Recent SEC Filing11/15/20214
President, Chief Executive Officer & DirectorSanjay S. Shukla
Chief Financial OfficerJill M. Broadfoot
Vice President-ResearchLeslie Nangle
Vice President-External Scientific AlliancesAndrew B. Cubitt

Company Highlights

Price Open$8.07
Previous Close$8.06
52 Week Range$3.48 - 13.10
Market Capitalization$216.8 M
Shares Outstanding27.8 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement03/22/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.04
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit Margin-1,468.14%
Return on Equity-50.25%

Analyst Ratings as of 10/11/2021

Buy
7
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset